KAREN AGEE: Open Payments
NPI 1184029100 · BROWNSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 41 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $267 |
| Novo Nordisk Inc | 7 | $142 |
| PFIZER INC. | 4 | $73 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| Amgen Inc. | 2 | $29 |
| Stryker Corporation | 1 | $24 |
| Lilly USA, LLC | 1 | $14 |
Products named: VRAYLAR, UBRELVY, Wegovy, ELIQUIS, TRELEGY ELLIPTA, Kerendia, Ozempic, CAPLYTA.
Industry payments across KY — which companies pay providers there.
